Following standard anti-TB therapy, we evaluated the level of dual (IFN-γ + TNF-α+) cytokine-producing CD4 + T cell activation and proliferation markers from M. tuberculosis-specific, smear-negative PTB patients. This evidence concerns the gene TNF and tuberculosis.